(Q37642594)

21 August 2017

1 reference

title

Clinical prognostic factors in multiple sclerosis: a natural history review (English)

1 reference

21 August 2017

0 references

Alexandra Degenhardt

1 reference

21 August 2017

Sreeram V Ramagopalan

series ordinal

1 reference

21 August 2017

Antonio Scalfari

series ordinal

1 reference

21 August 2017

George C Ebers

series ordinal

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

21 August 2017

published in

Nature Reviews Neurology

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

672-682

1 reference

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Factors associated with a rapid course of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Studies on the natural history of multiple sclerosis: 3. Epidemiologic analysis of the Army experience in World War II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

An epidemiologic study of multiple sclerosis in Northern Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Disability profile of MS did not change over 10 years in a population-based prevalence cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL.I. A CLINICAL ANALYSIS BASED ON A COUNTRY-WIDE SURVEY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Studies on natural history of multiple sclerosis. 4. Clinical features of the onset bout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognostic indicators in multiple sclerosis

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

31 March 2020

12 December 2020

Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Survival of multiple sclerosis in Finland between 1964 and 1993.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a regional study with some longitudinal data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Primary and secondary progressive multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Age at disability milestones in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Natural history of multiple sclerosis: a unifying concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Relapses and progression of disability in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Studies on the natural history of multiple sclerosis. V. Long-term survival in young men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Studies on the natural history of multiple sclerosis. 6. Clinical and laboratory findings at first diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognosis of multiple sclerosis. Results from an epidemiological area in Germany

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Natural history of primary progressive multiple sclerosis

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

31 March 2020

12 December 2020

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Factors Associated With a Malignant or Benign Course of Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL. II. A COMPARISON BETWEEN EUROPEAN AND AFRO-ASIAN PATIENTS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL. 3. CLINICAL COURSE AND PROGNOSIS RELATED TO AGE AT ONSET

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Survival and death in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Clinical factors associated with increased disability in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of primary progressive MS in British Columbia, Canada.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Disability progression in multiple sclerosis is slower than previously reported.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Predictive value of clinical characteristics for 'benign' multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Clinical characteristics of multiple sclerosis in Västerbotten County in northern Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Trends in survival and cause of death in Danish patients with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Long-term survival of patients with multiple sclerosis in West France.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prevalence of multiple sclerosis in Belgrade, Yugoslavia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Survival of multiple sclerosis patients in the Belgrade population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Life expectancy in patients attending multiple sclerosis clinics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Multiple sclerosis in Australia: prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

The effects of pregnancy in multiple sclerosis: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Multiple sclerosis and gestation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Prospective study of multiple sclerosis with early onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Early onset multiple sclerosis: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

Multiple sclerosis after age 50

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.178

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

31 March 2020

1 reference

12 December 2020

Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg

1 reference

12 December 2020

Onset symptoms as predictors of mortality and disability in multiple sclerosis

1 reference

12 December 2020

Clinical features of multiple sclerosis in north-east Scotland

1 reference

12 December 2020

Studies on the natural history of multiple sclerosis. 1. Design and diagnosis

1 reference

12 December 2020

Brainstem and cranial nerve involvement in multiple sclerosis

1 reference

12 December 2020

Clinical studies of multiple sclerosis in Iceland. A follow-up of previous survey and reappraisal

1 reference

12 December 2020

10.1038/NRNEUROL.2009.178

Identifiers

DOI

1 reference

21 August 2017

1 reference